☰

Dante S. Bortone, Ph.D. - Publications

Affiliations: 
Neurobiology University of California, San Diego, La Jolla, CA 
Area:
Developmental Neuroscience
Tree Info Grants Similar researchers PubMed Report error

6/31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Zang N, Issa JB, Ditri TB, Bortone DS, Touve MA, Rush AM, Scanziani M, Dombeck DA, Gianneschi NC. Multicolor Polymeric Nanoparticle Neuronal Tracers. Acs Central Science. 6: 436-445. PMID 32232144 DOI: 10.1021/Acscentsci.0C00027  0.64
2014 Bortone DS, Olsen SR, Scanziani M. Translaminar inhibitory cells recruited by layer 6 corticothalamic neurons suppress visual cortex. Neuron. 82: 474-85. PMID 24656931 DOI: 10.1016/J.Neuron.2014.02.021  0.72
2012 Olsen SR, Bortone DS, Adesnik H, Scanziani M. Gain control by layer six in cortical circuits of vision. Nature. 483: 47-52. PMID 22367547 DOI: 10.1038/Nature10835  0.674
2009 Bortone D, Polleux F. KCC2 expression promotes the termination of cortical interneuron migration in a voltage-sensitive calcium-dependent manner. Neuron. 62: 53-71. PMID 19376067 DOI: 10.1016/J.Neuron.2009.01.034  0.582
2006 Bortone DS, Mitchell K, Manis PB. Developmental time course of potassium channel expression in the rat cochlear nucleus. Hearing Research. 211: 114-25. PMID 16337757 DOI: 10.1016/J.Heares.2005.10.012  0.652
2005 Hand R, Bortone D, Mattar P, Nguyen L, Heng JI, Guerrier S, Boutt E, Peters E, Barnes AP, Parras C, Schuurmans C, Guillemot F, Polleux F. Phosphorylation of Neurogenin2 specifies the migration properties and the dendritic morphology of pyramidal neurons in the neocortex. Neuron. 48: 45-62. PMID 16202708 DOI: 10.1016/J.Neuron.2005.08.032  0.547
Low-probability matches (unlikely to be authored by this person)
2018 Smith CC, Beckermann KE, Bortone DS, de Cubas AA, Bixby LM, Lee SJ, Panda A, Ganesan S, Bhanot G, Wallen EM, Milowsky MI, Kim WY, Rathmell WK, Swanstrom R, Parker JS, et al. Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma. The Journal of Clinical Investigation. PMID 30137025 DOI: 10.1172/Jci121476  0.278
2018 Joseph R, Collins K, Bortone DS, Vincent BG, Yeh JJ, McRee AJ. Expression of immune genes and a signature of PD-1 inhibition resistance in basal-like pancreatic adenocarcinoma (PDAC) subtypes. Journal of Clinical Oncology. 36: 277-277. DOI: 10.1200/Jco.2018.36.4_Suppl.277  0.278
2018 Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, et al. The Immune Landscape of Cancer. Immunity. PMID 29628290 DOI: 10.1016/J.Immuni.2018.03.023  0.265
2019 Anders C, Moore D, Sambade M, Cuaboy L, Garrett A, Woodcock M, McKinnon K, Cowens K, Bortone D, Calhoun B, Carey L, Dees C, Jolly T, Muss H, Reeder-Hayes K, et al. Abstract P2-09-05: LCCC 1525: A phase II study of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer (mTNBC) Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P2-09-05  0.253
2018 Lee MS, Carlson C, Calvo BF, O'Neil BH, Bortone DS, Vincent BG. Abstract 3609: Differential gene expression is associated with response to chemoradiation and relapse-free and overall survival in rectal adenocarcinoma Cancer Research. 78: 3609-3609. DOI: 10.1158/1538-7445.Am2018-3609  0.253
2017 Nishijima TF, Kardos J, Chai S, Smith CC, Bortone DS, Mose LE, Selitsky SR, Sanoff HK, Parker JS, Lee MS, Vincent BG. Molecular and clinical characterization of a claudin (CLDN)-low subtype of gastric cancer (GC). Journal of Clinical Oncology. 35: 67-67. DOI: 10.1200/Jco.2017.35.4_Suppl.67  0.25
2018 Zeidner JF, Vincent BG, Ivanova A, Foster MC, Coombs CC, Jamieson K, Van Deventer HW, Blanchard L, Frank C, Gallagher S, Matson M, Pepin K, Vaught L, Vogler N, Miller K, ... ... Bortone DS, et al. Genomics Reveal Potential Biomarkers of Response to Pembrolizumab after High Dose Cytarabine in an Ongoing Phase II Trial in Relapsed/Refractory AML Blood. 132: 4054-4054. DOI: 10.1182/Blood-2018-99-116608  0.246
2013 Henderson L, Bortone DS, Lim C, Zambon AC. Classic "broken cell" techniques and newer live cell methods for cell cycle assessment. American Journal of Physiology. Cell Physiology. 304: C927-38. PMID 23392113 DOI: 10.1152/Ajpcell.00006.2013  0.238
2019 Free ME, Stember KG, Hess JJ, McInnis EA, Lardinois O, Hogan SL, Hu Y, Mendoza C, Le AK, Guseman AJ, Pilkinton MA, Bortone DS, Cowens K, Sidney J, Karosiene E, et al. Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis. Journal of Autoimmunity. 102306. PMID 31383567 DOI: 10.1016/J.Jaut.2019.102306  0.23
2018 Lee MS, Carlson CA, Calvo BF, O'Neil BH, McCoy NA, Bortone DS, Vincent BG, Keku TO. Association of mucosal Fusobacterium with clinical stage and immune gene signatures of rectal adenocarcinoma. Journal of Clinical Oncology. 36: 12112-12112. DOI: 10.1200/Jco.2018.36.15_Suppl.12112  0.221
2018 Lansford JL, Dharmasiri U, Chai S, Hunsucker SA, Bortone DS, Keating JE, Schlup IM, Glish GL, Collins EJ, Alatrash G, Molldrem JJ, Armistead PM, Vincent BG. Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens. Blood Advances. 2: 2052-2062. PMID 30115642 DOI: 10.1182/Bloodadvances.2018022475  0.216
2020 Smith CC, Bixby LM, Miller KL, Selitsky SR, Bortone DS, Hoadley KA, Vincent BG, Serody JS. Using RNA Sequencing to Characterize the Tumor Microenvironment. Methods in Molecular Biology (Clifton, N.J.). 2055: 245-272. PMID 31502156 DOI: 10.1007/978-1-4939-9773-2_12  0.212
2019 Stember K, McInnis E, Hogan S, Hu Y, Pilkinton M, Bortone D, Peters B, James E, Kwok W, Vincent B, Mallal S, Jennette C, Ciavatta D, Falk R, Free M. 191. CRITICAL MPO EPITOPES DRIVE THE CD4+ T CELL RESPONSE IN MPO-ANCA VASCULITIS Rheumatology. 58. DOI: 10.1093/Rheumatology/Kez061.005  0.21
2019 Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, et al. The Immune Landscape of Cancer. Immunity. 51: 411-412. PMID 31433971 DOI: 10.1016/J.Immuni.2019.08.004  0.198
2020 Woodcock M, Anders C, Swearingen AV, Moore D, Sambade M, Cuaboy L, Garrett A, McKinnon K, Cowens K, Bortone D, Calhoun B, Carey L, Dees C, Jolly T, Muss H, et al. 258 Scientific correlatives from LCCC 1525: a phase II study of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer Journal For Immunotherapy of Cancer. 8: A281-A282. DOI: 10.1136/JITC-2020-SITC2020.0258  0.116
2020 Vensko S, Vincent B, Bortone D. 485 RAFT: A framework to support rapid and reproducible immuno-oncology analyses Journal For Immunotherapy of Cancer. 8: A521-A521. DOI: 10.1136/jitc-2020-sitc2020.0485  0.103
2020 Bortone D, Vensko S, Entwistle S, Cogdill A, Monette A, Najjar Y, Sweis R, Tschernia N, Wennerberg E, Bommareddy P, Haymaker C, Khan U, McGee H, Park W, Sater H, et al. 75 Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cancer Journal For Immunotherapy of Cancer. 8: A81-A82. DOI: 10.1136/jitc-2020-sitc2020.0075  0.103
2022 Nishijima TF, Kardos J, Chai S, Smith CC, Bortone DS, Selitsky SR, Parker JS, Sanoff HK, Lee MS, Vincent BG. Molecular and Clinical Characterization of a Claudin-Low Subtype of Gastric Cancer. Jco Precision Oncology. 1: 1-10. PMID 35172495 DOI: 10.1200/PO.17.00047  0.1
2020 Wood CG, Ferguson JE, Parker JS, Moore DT, Whisenant JG, Maygarden SJ, Wallen EM, Kim WY, Milowsky MI, Beckermann KE, Davis NB, Haake SM, Karam JA, Bortone DS, Vincent BG, et al. Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma. Jci Insight. 5. PMID 33208553 DOI: 10.1172/jci.insight.132852  0.099
2022 Olsen KS, Jadi O, Dexheimer S, Bortone DS, Vensko SP, Bennett SN, Tang H, Diiorio M, Saran T, Dingfelder D, Zhu Q, Wang Y, Haiman CA, Pooler L, Sheng X, et al. Shared graft-vs-leukemia minor histocompatibility antigens in DISCOVeRY-BMT. Blood Advances. PMID 36477467 DOI: 10.1182/bloodadvances.2022008863  0.093
2023 Vensko SP, Olsen K, Bortone D, Smith CC, Chai S, Beckabir W, Fini M, Jadi O, Rubinsteyn A, Vincent BG. LENS: Landscape of Effective Neoantigens Software. Bioinformatics (Oxford, England). PMID 37184881 DOI: 10.1093/bioinformatics/btad322  0.091
2024 Di Modugno F, Di Carlo A, Spada S, Palermo B, D'Ambrosio L, D'Andrea D, Morello G, Belmonte B, Sperduti I, Balzano V, Gallo E, Melchionna R, Panetta M, Campo G, De Nicola F, ... ... Bortone DS, et al. Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer. Ebiomedicine. 101: 105003. PMID 38340557 DOI: 10.1016/j.ebiom.2024.105003  0.088
2020 Bortone DS, Woodcock MG, Parker JS, Vincent BG. Improved T cell receptor diversity estimates associate with survival and response to anti-PD-1 therapy. Cancer Immunology Research. PMID 33177107 DOI: 10.1158/2326-6066.CIR-20-0398  0.087
2022 Anders CK, Woodcock MG, Van Swearingen AED, Moore DT, Sambade MJ, Laurie S, Robeson A, Kolupaev O, Cuaboy LA, Garrett AL, McKinnon K, Cowens K, Bortone D, Calhoun BC, Wilkinson AD, et al. Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer. Journal For Immunotherapy of Cancer. 10. PMID 35121644 DOI: 10.1136/jitc-2021-003427  0.076
2006 Brienza N, Malcangi V, Dalfino L, Trerotoli P, Guagliardi C, Bortone D, Faconda G, Ribezzi M, Ancona G, Bruno F, Fiore T. A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Critical Care Medicine. 34: 707-14. PMID 16505657 DOI: 10.1097/01.CCM.0000201884.08872.A2  0.018
Hide low-probability matches.